Aug 2026· Phytomedicine· Vol 161, pp.
158713
· 0 citations· 69 references
Medicine
TL;DR
It is demonstrated that THP alleviates IBD by repairing the GVB through the S1P/S1PR2 axis, providing a mechanistic basis for GVB-targeted therapeutic strategies.
Abstract
Background
Inflammatory bowel disease (IBD) is a chronic, relapsing inflammatory disorder characterized by compromised intestinal barrier integrity.
Purpose
This study aimed to elucidate the therapeutic mechanisms of Tetrastigma hemsleyanum polysaccharides (THP) in restoring the gut vascular barrier (GVB) via the sphingosine-1-phosphate (S1P)/S1P receptor 2 (S1PR2) signaling axis.
Methods
A dextran sulfate sodium (DSS)-induced murine colitis model and tumor necrosis factor-α (TNF-α)/interferon-γ (IFN-γ)-stimulated human umbilical vein endothelial cells (HUVECs) were used. Multiple techniques including laser speckle contrast imaging, transmission electron microscopy, immunofluorescence, Western blotting, Transwell permeability assays, tube formation assays, and gene silencing were employed to evaluate the effects of THP.
Results
THP treatment significantly ameliorated clinical symptoms, histopathological damage, and pro-inflammatory cytokine secretion in colitis mice. Specifically, THP preserved GVB integrity by upregulating tight junction proteins (ZO-1, Claudin-1, Occludin) and adherens junction proteins (VE-cadherin, β-catenin) proteins, thereby reducing vascular permeability and suppressing pathological angiogenesis. Mechanistically, THP effectively modulated the S1P/S1PR2 signaling axis, there restoring endothelial homeostasis.
Conclusion
Collectively, this study demonstrates that THP alleviates IBD by repairing the GVB through the S1P/S1PR2 axis, providing a mechanistic basis for GVB-targeted therapeutic strategies.
4-MC treatment significantly ameliorated the disease manifestations of DSS-induced colitis, including weight loss, increased DAI, and colon shortening, and may protect against DSS-induced colitis by enhancing intestinal barrier function, attenuating inflammatory and oxidative stress responses, and suppressing NLRP3 inf...
Zi-Qiang Yang, Hong-Xiang Yuan, Wei-Qing Chen et al.· Central European Journal of...· 0 citations
ZFML003-EVs activate PPARγ to exert anti-inflammatory and barrier-repair effects, reshape gut microbiota and metabolism, and provide a theoretical basis for IBD-targeted therapy.
Ying-Jie Huang, La Xi, Bin Yu et al.· Journal of Agricultural and...· 0 citations
DOP markedly alleviated hepatic lipid accumulation, restored liver function abnormalities and mitigated hepatic pathological damage, and confers protective effects against MAFLD through remodeling gut microbiota and intestinal metabolites, preserving intestinal-barrier integrity, and inhibiting LPS-provoked hepatic TLR...
Yu-Mei Xu, Yan-Mei Zhang, Shu-Qi Li et al.· Frontiers in Pharmacology· 0 citations
Objective The integrity of the intestinal mucosal barrier is critical in the pathogenesis of Inflammatory Bowel Disease (IBD). While Astragaloside IV (ASIV) possesses potent anti-inflammatory properties, its specific effects on intestinal epithelial barrier function and the underlying mechanisms involving the Myosin Li...
Ming-Yue Yang, Yang Wang, Wen-Xiu Jia et al.· Frontiers in Pharmacology· 0 citations
Findings highlight XYS1-1, as a promising candidate for functional foods targeting liver health, while expanding insights into natural polysaccharide-based strategies against liver fibrosis, as a promising candidate for functional foods targeting liver health.
Ming-Hui Zhang, Qian-Xiao Chen, Ming-Xue Cha et al.· Food Science and Human Welln...· 0 citations
Findings indicate that C3G ameliorates experimental colitis, potentially through modulation of the PI3K-Akt pathway and suppression of epithelial apoptosis, supporting its potential as a functional food component for intestinal health.
Guang-Yi Du, Jia-Xin Li, Yang Xu et al.· Food & Function· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.